Open access
Sep 2026
Immune checkpoint inhibitors (ICIs) for second-line retreatment in esophageal cancer progressing after first-line immunotherapy: a single-center retrospective cohort study
The results of this study suggest that ICI retreatment showed measurable activity in a selected real-world cohort and deserves further evaluation in comparative studies.
Yi-Xin Kang, You-Jia Mi, Ce Zhang et al.
· Journal of Thoracic Disease · 0 citations